Skip to main content
Premium Trial:

Request an Annual Quote

James Herrmann, Kevin Conroy, Slava Elagin, David Schwartz, Gregory Gosch, and Elliott Sigal


David Nuti will step down as CFO of Third Wave Technologies on Oct. 29, the company said this week. He will be replaced by James Herrmann, who recently joined the company as vice president of finance. Most recently, Herrmann was a general partner in an electronics distribution company. Nuti will help with the transition until the end of the year.

In addition, Kevin Conroy has been promoted to Third Wave's general counsel and secretary, from vice president of legal affairs. He replaces John Comerford, who will be leaving the company to pursue other interests after a transition period.

Also, Slava Elagin has become vice president for research and development. He joined the company last June as head of infectious disease research and development.

David Schwartz will be the new director of the National Institute of Environmental Health Sciences and the National Toxicology Program, the NIH said on Monday. He will replace Kenneth Olden, who stepped down as NIEHS director last year, and will take up his appointment on April 4. Schwartz is currently the director of the pulmonary, allergy, and critical care division and vice chair of research in the department of medicine at Duke University.

Gregory Gosch has become vice president of marketing for Luminex. He was senior director for sales and marketing at Nanogen.

Elliott Sigal has been named acting president of the Bristol-Myers Squibb Pharmaceutical Research Institute. He covers for James Palmer, the current president, who recently underwent surgery. Sigal is senior vice president for global clinical and pharmaceutical development at Bristol-Myers Squibb.

Filed under